Fig. 2From: Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classificationBox plots showing the T/N ratios of MET (a) and FLT (b) in relation to IDH1 mutation status in all gliomas (n = 81). The tracer uptake in IDH1-wildtype (wt) tumours was significantly higher than that in IDH1-mutant (mut) tumours both in MET-PET (P < 0.001) and FLT-PET (P < 0.001)Back to article page